| Mary Bronwyn Long, CNS, ACHPN | |
|
1400 Jackson St, Denver, CO 80206-2761 | |
| (303) 388-4461 | |
| (303) 270-2206 |
| Full Name | Mary Bronwyn Long |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 17 Years |
| Location | 1400 Jackson St, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013188663 | NPI | - | NPPES |
| 65976754 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | 173629 (Colorado) | Secondary |
| 364S00000X | Clinical Nurse Specialist | R1827185 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| National Jewish Health | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| National Jewish Health | 4587577028 | 220 |
News Archive
When it comes to healthcare, an innovative team approach is essential to providing excellent patient care, advancing research, and educating future healthcare providers. The fall/winter 2010 issue of Johns Hopkins Nursing explores how today's nurses work to bridge disciplines and discover new collaborative opportunities.
An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
› Verified 9 days ago
| Entity Name | National Jewish Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326015777 PECOS PAC ID: 4587577028 Enrollment ID: O20031110000757 |
News Archive
When it comes to healthcare, an innovative team approach is essential to providing excellent patient care, advancing research, and educating future healthcare providers. The fall/winter 2010 issue of Johns Hopkins Nursing explores how today's nurses work to bridge disciplines and discover new collaborative opportunities.
An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Bronwyn Long, CNS, ACHPN 1400 Jackson St, Denver, CO 80206-2761 Ph: (303) 388-4461 | Mary Bronwyn Long, CNS, ACHPN 1400 Jackson St, Denver, CO 80206-2761 Ph: (303) 388-4461 |
News Archive
When it comes to healthcare, an innovative team approach is essential to providing excellent patient care, advancing research, and educating future healthcare providers. The fall/winter 2010 issue of Johns Hopkins Nursing explores how today's nurses work to bridge disciplines and discover new collaborative opportunities.
An international research team, co-led by scientists at Mayo Clinic's campus in Florida, have discovered three potential susceptibility genes for development of progressive supranuclear palsy (PSP), a rare neurodegenerative disease that causes symptoms similar to those of Parkinson's disease but is resistant to Parkinson's medications.
Based on its recent analysis of the pharmaceutical drug delivery industry, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership. Acino's expertise in targeted drug release profiles and strong technical know-how in pellet-coating, transdermal therapeutic patches and biodegradable implants has made it the preferred vendor in contract manufacturing.
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
› Verified 9 days ago
Ms. Donna Strickland, MS, RN, PMHCNS-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 7772 E 8th Pl, Denver, CO 80230 Phone: 303-808-4880 | |
Mrs. Rosalie Jo Bush, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1056 E 19th Ave, Box 395, Denver, CO 80218 Phone: 303-864-5622 Fax: 303-837-2924 | |
Noriko Saito Rothberg, NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2975 Roslyn St, Denver, CO 80238 Phone: 303-399-7900 Fax: 303-399-7999 | |
Kari Fitzpatrick Ballou, MSN, RN, CNOR Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2170 S Parker Rd, #400, Denver, CO 80231 Phone: 303-755-6304 | |
Ms. Kathryn Ann Terrill, MSN, PMHCNS-BC, RXN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 90 Madison Street, Suite 102, Denver, CO 80206 Phone: 720-331-6899 Fax: 720-306-5499 | |
Mrs. Maureen Doran, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 900 S Garfield St, Denver, CO 80209 Phone: 303-744-3086 Fax: 303-744-3086 |